Cellular metabolism via provision of exogenous glucose

Cellular metabolism via provision of exogenous glucose" is not a specific molecular target such as a receptor, enzyme, transporter, or protein. Instead, it refers to the broad biological process whereby cells utilize externally supplied (exogenous) glucose for energy production and biosynthetic pathways. Exogenous glucose enters cells primarily through facilitated diffusion mediated by various members of the GLUT family of transporters. Once inside the cell, it is phosphorylated and can enter several metabolic fates including glycolysis (for ATP generation), glycogen synthesis/storage, pentose phosphate pathway for nucleotide synthesis/reducing equivalents, hexosamine biosynthetic pathway for protein glycosylation modifications,[1] and conversion into lipids.[1][3] This process is central to normal physiology—supporting energy needs during feeding—and is tightly regulated by hormones such as insulin and glucagon.[2] In disease states like cancer, increased exogenous glucose supply can drive abnormal cell proliferation through enhanced aerobic glycolysis ("Warburg effect"), which underpins both diagnostic imaging strategies like FDG-PET scans and therapeutic approaches targeting altered tumor metabolism.[4] In diabetes mellitus type 2, defects in cellular handling of both endogenous and exogenous sources contribute to hyperglycemia.[3] Because "cellular metabolism via provision of exogenous glucose" describes a physiological phenomenon rather than a discrete molecular entity or druggable target molecule/protein complex,[5] it should not be considered an individual therapeutic target per se.

Modulation of glycolysis and oxidative phosphorylation by altering extracellular glucose availability[3][4] Regulation of insulin-mediated glucose uptake into cells[2]